Next Article in Journal
Spirulina Platensis Supplementation Coupled to Strength Exercise Improves Redox Balance and Reduces Intestinal Contractile Reactivity in Rat Ileum
Next Article in Special Issue
Syntheses and Glycosidase Inhibitory Activities, and in Silico Docking Studies of Pericosine E Analogs Methoxy-Substituted at C6
Previous Article in Journal
Photoprotective Activity of Topsentin, A Bis(Indole) Alkaloid from the Marine Sponge Spongosorites genitrix, by Regulation of COX-2 and Mir-4485 Expression in UVB-Irradiated Human Keratinocyte Cells
Previous Article in Special Issue
Modulation of the Liver Protein Carbonylome by the Combined Effect of Marine Omega-3 PUFAs and Grape Polyphenols Supplementation in Rats Fed an Obesogenic High Fat and High Sucrose Diet
Open AccessArticle

The Marine Seagrass Halophila stipulacea as a Source of Bioactive Metabolites against Obesity and Biofouling

Research Laboratory (LR14-ES06): Bioresources: Integrative Biology and Valorization, High Institute of Biotechnology of Monastir, University of Monastir, Monastir 5000, Tunisia
Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto, Avenida General Norton de Matos, s/n, 4450-208 Matosinhos, Portugal
Department of Biology, FCUP, Faculty of Science, University of Porto, Rua do Campo, Alegre, 4169-007 Porto, Portugal
Author to whom correspondence should be addressed.
Mar. Drugs 2020, 18(2), 88;
Received: 19 December 2019 / Revised: 18 January 2020 / Accepted: 27 January 2020 / Published: 29 January 2020
(This article belongs to the Special Issue Marine Natural Products and Obesity 2020)
Marine organisms, including seagrasses, are important sources of biologically active molecules for the treatment of human diseases. In this study, organic extracts of the marine seagrass Halophila stipulacea obtained by different polarities from leaves (L) and stems (S) (hexane [HL, HS], ethyl acetate [EL, ES], and methanol [ML, MS]) were tested for different bioactivities. The screening comprehended the cytotoxicity activity against cancer cell lines grown as a monolayer culture or as multicellular spheroids (cancer), glucose uptake in cells (diabetes), reduction of lipid content in fatty acid-overloaded liver cells (steatosis), and lipid-reducing activity in zebrafish larvae (obesity), as well as the antifouling activity against marine bacteria (microfouling) and mussel larval settlement (macrofouling). HL, EL, HS, and ES extracts showed statistically significant cytotoxicity against cancer cell lines. The extracts did not have any significant effect on glucose uptake and on the reduction of lipids in liver cells. The EL and ML extracts reduced neutral lipid contents on the larvae of zebrafish with EC50 values of 2.2 µg/mL for EL and 1.2 µg/mL for ML. For the antifouling activity, the HS and ML extracts showed a significant inhibitory effect (p < 0.05) against the settlement of Mytilus galloprovincialis plantigrade larvae. The metabolite profiling using HR-LC-MS/MS and GNPS (The Global Natural Product Social Molecular Networking) analyses identified a variety of known primary and secondary metabolites in the extracts, along with some unreported molecules. Various compounds were detected with known activities on cancer (polyphenols: Luteolin, apeginin, matairesinol), on metabolic diseases (polyphenols: cirsimarin, spiraeoside, 2,4-dihydroxyheptadec-16-ynyl acetate; amino acids: N-acetyl-L-tyrosine), or on antifouling (fatty acids: 13-decosenamide; cinnamic acids: 3-hydroxy-4-methoxycinnamic acid, alpha-cyano-4-hydroxycinnamic), which could be, in part, responsible for the observed bioactivities. In summary, this study revealed that Halophila stipulacea is a rich source of metabolites with promising activities against obesity and biofouling and suggests that this seagrass could be useful for drug discovery in the future. View Full-Text
Keywords: Halophila stipulacea; extracts; bioactivity; cytotoxicity; anti-obesity; antifouling Halophila stipulacea; extracts; bioactivity; cytotoxicity; anti-obesity; antifouling
Show Figures

Figure 1

MDPI and ACS Style

Bel Mabrouk, S.; Reis, M.; Sousa, M.L.; Ribeiro, T.; Almeida, J.R.; Pereira, S.; Antunes, J.; Rosa, F.; Vasconcelos, V.; Achour, L.; Kacem, A.; Urbatzka, R. The Marine Seagrass Halophila stipulacea as a Source of Bioactive Metabolites against Obesity and Biofouling. Mar. Drugs 2020, 18, 88.

AMA Style

Bel Mabrouk S, Reis M, Sousa ML, Ribeiro T, Almeida JR, Pereira S, Antunes J, Rosa F, Vasconcelos V, Achour L, Kacem A, Urbatzka R. The Marine Seagrass Halophila stipulacea as a Source of Bioactive Metabolites against Obesity and Biofouling. Marine Drugs. 2020; 18(2):88.

Chicago/Turabian Style

Bel Mabrouk, Sawssen; Reis, Mariana; Sousa, Maria L.; Ribeiro, Tiago; Almeida, Joana R.; Pereira, Sandra; Antunes, Jorge; Rosa, Filipa; Vasconcelos, Vitor; Achour, Lotfi; Kacem, Adnen; Urbatzka, Ralph. 2020. "The Marine Seagrass Halophila stipulacea as a Source of Bioactive Metabolites against Obesity and Biofouling" Mar. Drugs 18, no. 2: 88.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop